Human Molecular Genetics, 2002, Vol. 11, No. 23 2929-2940
© 2002 Oxford University Press
Expression analysis of RSK gene family members: the RSK2 gene, mutated in Coffin–Lowry syndrome, is prominently expressed in brain structures essential for cognitive function and learning
1Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS/INSERM/ULP, B.P. 10142, 67404 Illkirch Cedex, C.U. de Strasbourg, France and 2Department of Medicine, University College London, London, WC1E 6JJ, UK
Received July 15, 2002; Accepted August 28, 2002
Coffin–Lowry syndrome (CLS) is characterized by cognitive impairment, characteristic facial and digital findings and skeletal anomalies. The gene implicated in CLS encodes RSK2, a serine/threonine kinase acting in the Ras/MAPK signalling pathway. In humans, RSK2 belongs to a family of four highly homologous proteins (RSK1–RSK4), encoded by distinct genes. RSK2 mutations in CLS patients are extremely heterogeneous. No consistent relationship between specific mutations and the severity of the disease or the expression of uncommon features has been established. Together, the data suggest an influence of environmental and/or other genetic components on the presentation of the disease. Obvious modifying genes include those encoding other RSK family members. In this study we have determined the expression of RSK1, 2 and 3 genes in various human tissues, during mouse embryogenesis and in mouse brain. The three RSK mRNAs were expressed in all human tissues and brain regions tested, supporting functional redundancy. However, tissue specific variations in levels suggest that they may also serve specific roles. The mouse Rsk3 gene was prominently expressed in the developing neural and sensory tissues, whereas Rsk1 gene expression was the strongest in various other tissues with high proliferative activity, suggesting distinct roles during development. In adult mouse brain, the highest levels of Rsk2 expression were observed in regions with high synaptic activity, including the neocortex, the hippocampus and Purkinje cells. These structures are essential components in cognitive function and learning. Based on the expression levels, our results suggest that in these areas, the Rsk1 and Rsk3 genes may not be able to fully compensate for a lack of Rsk2 function.
* To whom correspondence should be addressed at: I.G.B.M.C., B.P. 10142, 67404 Illkirch Cedex, C.U. de Strasbourg, France. Tel: +33 388653400; Fax: +33 388653246; Email: andre.hanauer{at}titus.u-strasbg.fr
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  P. Tsokas, T. Ma, R. Iyengar, E. M. Landau, and R. D. Blitzer Mitogen-Activated Protein Kinase Upregulates the Dendritic Translation Machinery in Long-Term Potentiation by Controlling the Mammalian Target of Rapamycin Pathway J. Neurosci., May 30, 2007; 27(22): 5885 - 5894. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Falco, C. Romano, A. Alberti, D. Greco, C. Scuderi, E. Avola, P. Failla, S. Belli, J. L. Tolmie, S. Amata, et al. Identification of Novel Mutations in Patients with Coffin-Lowry Syndrome by a Denaturing HPLC-Based Assay Clin. Chem., December 1, 2005; 51(12): 2356 - 2358. [Full Text] [PDF]
|
|
|
|
 |
|
 G. M. Thomas, G. R. Rumbaugh, D. B. Harrar, and R. L. Huganir Ribosomal S6 kinase 2 interacts with and phosphorylates PDZ domain-containing proteins and regulates AMPA receptor transmission PNAS, October 18, 2005; 102(42): 15006 - 15011. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Silverman, M. Frodin, S. Gammeltoft, and J. L. Maller Activation of p90Rsk1 Is Sufficient for Differentiation of PC12 Cells Mol. Cell. Biol., December 15, 2004; 24(24): 10573 - 10583. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. P. Roux and J. Blenis ERK and p38 MAPK-Activated Protein Kinases: a Family of Protein Kinases with Diverse Biological Functions Microbiol. Mol. Biol. Rev., June 1, 2004; 68(2): 320 - 344. [Abstract] [Full Text] [PDF]
|
|